CDHR3
Cadherin-related family member 3
Also known as: CDH28, CDHR3_HUMAN, FLJ23834, FLJ44366
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZTQ4
- Gene
- CDHR3
- Ensembl
- ENSG00000128536
- Chromosome
- 7
- Canonical length
- 885 aa
- Protein class
- Disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable beta-catenin binding activity and cadherin binding activity. Predicted to be involved in several processes, including calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; cell-cell adhesion mediated by cadherin; and cell-cell junction organization. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
885 residues, UniProt reviewed canonical sequence.
>Q6ZTQ4|CDHR3
1 MQEAIILLAL LGAMSGGEAL HLILLPATGN VAENSPPGTS VHKFSVKLSA SLSPVIPGFP
61 QIVNSNPLTE AFRVNWLSGT YFEVVTTGME QLDFETGPNI FDLQIYVKDE VGVTDLQVLT
121 VQVTDVNEPP QFQGNLAEGL HLYIVERANP GFIYQVEAFD PEDTSRNIPL SYFLISPPKS
181 FRMSANGTLF STTELDFEAG HRSFHLIVEV RDSGGLKAST ELQVNIVNLN DEVPRFTSPT
241 RVYTVLEELS PGTIVANITA EDPDDEGFPS HLLYSITTVS KYFMINQLTG TIQVAQRIDR
301 DAGELRQNPT ISLEVLVKDR PYGGQENRIQ ITFIVEDVND NPATCQKFTF SIMVPERTAK
361 GTLLLDLNKF CFDDDSEAPN NRFNFTMPSG VGSGSRFLQD PAGSGKIVLI GDLDYENPSN
421 LAAGNKYTVI IQVQDVAPPY YKNNVYVYIL TSPENEFPLI FDRPSYVFDV SERRPARTRV
481 GQVRATDKDL PQSSLLYSIS TGGASLQYPN VFWINPKTGE LQLVTKVDCE TTPIYILRIQ
541 ATNNEDTSSV TVTVNILEEN DEKPICTPNS YFLALPVDLK VGTNIQNFKL TCTDLDSSPR
601 SFRYSIGPGN VNNHFTFSPN AGSNVTRLLL TSRFDYAGGF DKIWDYKLLV YVTDDNLMSD
661 RKKAEALVET GTVTLSIKVI PHPTTIITTT PRPRVTYQVL RKNVYSPSAW YVPFVITLGS
721 ILLLGLLVYL VVLLAKAIHR HCPCKTGKNK EPLTKKGETK TAERDVVVET IQMNTIFDGE
781 AIDPVTGETY EFNSKTGARK WKDPLTQMPK WKESSHQGAA PRRVTAGEGM GSLRSANWEE
841 DELSGKAWAE DAGLGSRNEG GKLGNPKNRN PAFMNRAYPK PHPGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDHR3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 102 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 102 nTPM
- choroid plexus: 34 nTPM
- lung: 15 nTPM
- cerebellum: 11 nTPM
- stomach: 8.7 nTPM
- basal ganglia: 7.4 nTPM
Single-cell type
- respiratory ciliated cells: 2,227 nCPM
- fallopian tube ciliated cells: 1,066 nCPM
- endometrial ciliated cells: 819 nCPM
- neuroendocrine cells: 619 nCPM
- ependymal cells: 490 nCPM
- choroid plexus epithelial cells: 412 nCPM
Immune cell
- naive B-cell: 2.9 nTPM
- memory B-cell: 2 nTPM
- neutrophil: 0.9 nTPM
- NK-cell: 0.3 nTPM
- T-reg: 0.3 nTPM
- basophil: 0.1 nTPM
Brain region
- choroid plexus: 101 nTPM
- midbrain: 47 nTPM
- medulla oblongata: 25 nTPM
- pons: 20 nTPM
- spinal cord: 19 nTPM
- thalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction organization
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell migration
- cell morphogenesis
- cell-cell adhesion mediated by cadherin
- cell-cell junction assembly
- homophilic cell adhesion via plasma membrane adhesion molecules
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDHR3 as an antibody target. Whether an autoantibody or antibody against CDHR3 could matter depends on whether native CDHR3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDHR3 is annotated at the cell surface, where native CDHR3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDHR3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...